Senior Director
Johnson & Johnson Innovative Medicine
Spring House, Pennsylvania
Dr. Tong-yuan Yang currently is Senior Director at Preclinical Sciences and Translational Safety, Johnson & Johnson Innovative Medicine. He has over twenty years of experience in biopharmaceutics ranged from drug discovery, development to market approval. He manages a group of scientists to develop and validate immunological and biochemical assays to support characterizing pharmacokinetics (PK) and immunogenicity of biologics, siRNA, peptide, CAR-T and gene therapy products in nonclinical and clinical settings. He has contributed to 12 marketed product approvals. He is an active member of the American Association of Pharmaceutical Sciences. He has over 40 publications in peer-reviewed journals, multiple patents, and is frequently invited speakers at various conferences. He received his medical degree from Beijing Medical University (Now Peking University Health Science Center) and Ph.D. in Molecular Virology from Pennsylvania State University College of Medicine where he also holds an adjunct professorship at Department of Neurosciences and Experimental Therapeutics.
Disclosure information not submitted.
Clinical ADA Method: Universal vs In Study Cut Point?
Tuesday, July 14, 2026
1:35 PM - 2:05 PM East Coast USA Time